This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (377)

Published on in Vol 9, No 2 (2020): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17082, first published .
Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Adjuvant Alpha-Fetoprotein-Derived Peptide After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: Protocol for a Safety Study

Authors of this article:

Akihiro Nomura 1 Author Orcid Image ;   Takeshi Terashima 2 Author Orcid Image ;   Eishiro Mizukoshi 2 Author Orcid Image ;   Masaaki Kitahara 2 Author Orcid Image ;   Toshinori Murayama 1 Author Orcid Image ;   Shuichi Kaneko 2 Author Orcid Image
Article Authors Cited by Tweetations (1) Metrics
Akihiro Nomura 1, MD, PhD;  Takeshi Terashima 2, MD, PhD;  Eishiro Mizukoshi 2, MD, PhD;  Masaaki Kitahara 2, MD, PhD;  Toshinori Murayama 1, MD, PhD;  Shuichi Kaneko 2, MD, PhD

1 Innovative Clinical Research Center, Kanazawa University , Kanazawa , JP

2 Department of Gastroenterology, Kanazawa University Hospital , Kanazawa , JP

Corresponding Author: